| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 03/10/2011 | US20110059158 Charged phospholipid compositions and methods for their use |
| 03/10/2011 | US20110059117 Liquid Compositions Capable of Foaming and Including Active Agents, and Methods for Making or Developing Same |
| 03/10/2011 | US20110059099 Treatment of idiopathic thrombocytopenic purpura |
| 03/10/2011 | US20110059080 Use of an anti-il6 antibody to decrease hepcidin in cancer patients |
| 03/10/2011 | US20110059073 Method for treating infectious disease using monoclonal antibodies |
| 03/10/2011 | US20110059072 Method for treating cancer using monoclonal antibodies |
| 03/10/2011 | US20110059036 Nitric oxide-releasing polymers |
| 03/10/2011 | CA2772051A1 Coagulation factor ix compositions and methods of making and using same |
| 03/10/2011 | CA2771999A1 Coagulation factor vii compositions and methods of making and using same |
| 03/09/2011 | EP2292771A2 Sense mRNA therapy |
| 03/09/2011 | EP2292734A1 Hematopoietic cells from human embryonic stem cells |
| 03/09/2011 | EP2292657A1 Reduced side-effect hemoglobin compositions |
| 03/09/2011 | EP2292651A1 Methods and compositions for the prevention and treatment of anemia |
| 03/09/2011 | EP2292650A1 Methods and compositions for the prevention and treatment of anemia |
| 03/09/2011 | EP2292640A2 Base-substituted benzylamine analogs for use as coagulation factor Xa inhibitors, the production and use thereof |
| 03/09/2011 | EP2292631A1 Regeneration of endogenous myocardial tissue by induction of neovascularization |
| 03/09/2011 | EP2292622A1 New crystalline form of a triazolo(4,5-d)pyrimidine compound |
| 03/09/2011 | EP2292616A1 Novel polymorphic form and the amorphous form of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide |
| 03/09/2011 | EP2292611A1 Novel thiophenediamine derivative having urea structure |
| 03/09/2011 | EP2292610A1 Macrolides with VEGF transcription suppression activity |
| 03/09/2011 | EP2292273A2 Remodeling and glycoconjugation of peptides |
| 03/09/2011 | EP2292271A2 Remodelling and glycoconjugation of an antibody |
| 03/09/2011 | EP2292232A1 Beta-amino tetrahydroimidazo(1,2-A)pyrazines and tetrahydrotriazolo(4,3-A)pyrazines for use in the treatment of diabetes type II |
| 03/09/2011 | EP2292225A1 Dosage form comprising taxol in crystalline form |
| 03/09/2011 | EP2292216A2 Stable pharmaceutical composition containing factor VIII |
| 03/09/2011 | EP2291379A1 Substituted quinazolines |
| 03/09/2011 | EP1991271B1 Anticoagulant antithrombotic dual inhibitors comprising a biotin label |
| 03/09/2011 | EP1748069B1 Follistatin mutant polypeptide |
| 03/09/2011 | EP1585730B1 Carboxamide derivatives and their use as factor xa inhibitors |
| 03/09/2011 | EP1499297B1 Pharmaceutical formulation comprising atorvastatin calcium |
| 03/09/2011 | EP1315513B1 "pseudo"-native chemical ligation |
| 03/09/2011 | CN1824255B Curcuma zedoary oil solid lipid nano-particle and its preparation method |
| 03/09/2011 | CN1582274B Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 03/09/2011 | CN101984759A Modulation of factor 9 expression |
| 03/09/2011 | CN101984314A Preparation method for dry extract of total saponins of rehmannia leaves |
| 03/09/2011 | CN101984035A Health wine and preparation method thereof |
| 03/09/2011 | CN101983694A Traditional Chinese medicine for treating cerebral haemorrhage |
| 03/09/2011 | CN101983677A Medicament for treating epistaxis |
| 03/09/2011 | CN101983664A Agent for quickly removing congestion blocks |
| 03/09/2011 | CN101983660A Chinese traditional medicine composition for enriching blood and beautifying face and preparation method thereof |
| 03/09/2011 | CN101983655A Medicament for treating metrorrhagia |
| 03/09/2011 | CN101983641A Medicament for treating thromboangiitis obliterans |
| 03/09/2011 | CN101444532B Processing method for effectively dissolving out efficacy ingredient estrogen in deer fetus powder |
| 03/08/2011 | US7902223 Phenyl derivatives as factor XA inhibitors |
| 03/08/2011 | US7901716 Active fraction having anti-cancer and anti-metastasis isolated from leaves and stems of ginseng |
| 03/08/2011 | CA2486915C Active fraction having anti-cancer and anti-metastasis isolated from leaves and stems of ginseng |
| 03/08/2011 | CA2464721C Nitrogenous (tetrahydropyridyl) (alkyl) heterocycles with tnf activity |
| 03/08/2011 | CA2343840C Use of a cytokine-producing lactococcus strain to treat colitis |
| 03/08/2011 | CA2137377C Retinal pigmented epithelium derived neurotrophic factor |
| 03/03/2011 | WO2011025565A1 Morpholinone compounds as factor ixa inhibitors |
| 03/03/2011 | WO2011024962A1 Therapeutic agent for liver-related diseases |
| 03/03/2011 | WO2011024933A1 3-(biaryloxy) propionic acid derivative |
| 03/03/2011 | WO2011024918A1 Antiangiogenic agent and method for inhibition of angiogenesis |
| 03/03/2011 | WO2011024874A1 Base addition salts |
| 03/03/2011 | WO2011024480A1 Drug composition for angiogenesis therapy |
| 03/03/2011 | WO2011024025A1 An erythropoietin analogue and a method thereof |
| 03/03/2011 | WO2011023703A1 Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof |
| 03/03/2011 | WO2010065479A9 Compositions and methods using alpha beta-crystallin in protecting the myocardium from ischemia/reperfusion injury |
| 03/03/2011 | US20110054017 Substituted furans and their use |
| 03/03/2011 | US20110054005 Polynucleotides for causing RNA interference and method for inhibiting gene expression using the same |
| 03/03/2011 | US20110053993 Prodrugs of desazadesferrothiocin polyether analogues as metal chelation agents |
| 03/03/2011 | US20110053974 Carboxylic acid compound |
| 03/03/2011 | US20110053959 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 03/03/2011 | US20110053958 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 03/03/2011 | US20110053933 Hydroxyquinoxalinecarboxamide derivative |
| 03/03/2011 | US20110053930 Inhibitors of the bmp signaling pathway |
| 03/03/2011 | US20110053929 Imidazo-, pyrazolopyrazines and imidazotriazines and their use |
| 03/03/2011 | US20110053925 Hydroxamate-Based Inhibitors of Deacetylases |
| 03/03/2011 | US20110053897 Compounds and compositions as syk kinase inhibitors |
| 03/03/2011 | US20110053895 Use of mitochondrially-addressed compounds for preventing and treating cardiovascular diseases |
| 03/03/2011 | US20110053851 Haemostasis-modulating compositions and uses therefor |
| 03/03/2011 | US20110052732 Mineral absorption accelerator and iron deficiency anemia improver of food composition |
| 03/03/2011 | US20110052728 Botanical extract from the aqueous stream of the palm oil milling process for the prevention and inhibition of oxidative stress and haemolysis in human red blood cells |
| 03/03/2011 | US20110052670 Identification of a pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell |
| 03/03/2011 | US20110052665 Haemostatic material |
| 03/03/2011 | US20110052645 Manufacture of multiple minicapsules |
| 03/03/2011 | US20110052616 Biological materials and uses thereof |
| 03/03/2011 | US20110052571 Method for treating idiopathic thrombocytopenic purpura using monoclonal antibodies |
| 03/03/2011 | CA2772164A1 Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof |
| 03/03/2011 | CA2771601A1 Morpholinone compounds as factor ixa inhibitors |
| 03/03/2011 | CA2771328A1 Cofactors for thrombin activation of factor vii and uses thereof |
| 03/02/2011 | EP2289944A2 Bispecific antibody substituting for functional proteins |
| 03/02/2011 | EP2289879A1 Synthesis of a crytalline form of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide tartrate salt |
| 03/02/2011 | EP2289566A1 Medical device comprising a haemostatic agent and haemostatic kit comprising the medical device |
| 03/02/2011 | EP2289551A1 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 03/02/2011 | EP2289531A2 Medicaments for increasing endogenous erythropoietine (EPO) |
| 03/02/2011 | EP2288606A1 New co-crystal compound of rivaroxaban and malonic acid |
| 03/02/2011 | EP2288365A1 Targeted coagulation factors and method of using the same |
| 03/02/2011 | EP2046748B1 Phenylpentadienoyl derivatives and their use as par 1 antagonists |
| 03/02/2011 | EP1686951B1 Combined cosmetic or therapeutic preparation |
| 03/02/2011 | EP1656131B1 Use of betaine for treating intermittent claudication |
| 03/02/2011 | CN101983072A Mineral absorption accelerator and iron deficiency anemia improver or food composition |
| 03/02/2011 | CN101983056A Preventive and/or remedy for vascular diseases |
| 03/02/2011 | CN101982172A Combined drug of Ginkgolide and Ginkgo flavone as well as preparation and application thereof |
| 03/02/2011 | CN101193656B Novel triglyceride reducing agent |
| 03/02/2011 | CN101185649B Levoleucovorin freeze-dried injection agent and preparation method and pharmaceutical use thereof |
| 03/02/2011 | CN101084889B Ginkgolide freezing-dried powder injection and preparation method thereof |
| 03/02/2011 | CN101073365B Lily health-care heat-clearing tea and its production |
| 03/02/2011 | CN101020637B Preparation process and application of resemary acid |
| 03/01/2011 | US7897729 Polymeric immunoglobulin fusion proteins that target low affinity FcγReceptors |